Publications
Select a year : 2025 – 2024 – 2023 – 2022 – 2021 – 2020 – 2019 – 2018 – 2017 – 2016 – 2015 – 2014 – 2013 – 2012 – 2011 – 2010 – 2009 – 2008 – 2007 – 2006 – 2005 – 2004 – 2003 – 2002 – 2001 – 2000 – 1999 – 1998 – 1997 – All Years
2025
- Matsoukas, MT. Ciruela-Jardí, M. Gallo, M. Ferre, S. Andreu, D. Casadó, V. Pardo, L. Moreno, E.
“Design of Small Non-Peptidic Ligands That Alter Heteromerization between Cannabinoid CB(1) and Serotonin 5HT(2A) Receptors.”
J Med Chem 68(1) 261–269
- Evans AH, Ciruela-Jardí M, Rea W, Keegan BM, Levinstein MR, Bonifazi A, Cao J, Jackson SN, Shi L, Casajuana-Martin N, Cai NS, Casadó V, Earley CJ, Newman AH, Michaelides M, Pardo L, Moreno E, Ferré S
“Locomotor activity depends on β-arrestin recruitment by the dopamine D1 receptor in the striatal D1-D3 receptor heteromer”
Pharmacol Res. 218(0) 107826– - Sanchez WN, Moreno E, Ciruela-Jardí M, Casajuana-Martín N, Yauch A, Cai NS, Quiroz C, Chang YG, Casadó V, Pardo L, Plant LD, Ferré S
“Distinctive biochemical properties of the μ-opioid receptor-corticotropin- releasing factor CRF1 receptor heterotetramer.”
Pharmacol Res. 219(0) 107904– - Levinstein MR, De Oliveira PA, Casajuana-Martin N, Quiroz C, Budinich RC, Rais R, Rea W, Ventriglia EN, Llopart N, Casadó-Anguera V, Moreno E, Walther D, Glatfelter GC, Weinshenker D, Zarate CA Jr, Casadó V, Baumann MH, Pardo L, Ferré S, Michaelides M.
“Reply to “Letter to the Editor regarding ‘Unique pharmacodynamic properties and low abuse liability of the μ-opioid receptor ligand (S)-methadone’”
Mol Psychiatry. 30(0) 1708–1709 - Ferré S, Ciruela F, Pardo L.
“Functional significance of opioid receptor homomers and heteromers.”
Nat Commun. 16(0) 9857– - Llinas Del Torrent C, Raïch I, Gonzalez A, Lillo J, Casajuana-Martin N, Franco R, Pardo L, Navarro G.
“Allosterism in the adenosine A2A and cannabinoid CB2 heteromer.”
Br J Pharmacol. 182(0) 3371–3384 - Quintana-Garcia A, Raïch I, Del Llinas Del Torrent C, Lillo J, Casajuana- Martin N, Rebassa JB, Navarro G, Pardo L.
“Metadynamics simulations and site- directed mutagenesis determine the binding of cannabidiol to the adenosine A2A receptor.”
Protein Sci. 34(0) e70394–